1649 – Modification of the wording of minimally invasive glaucoma surgery (MIGS) existing item number to encompass the use of a microcatheter

Page last updated: 30 March 2022

Application Detail

Description of Medical Service

Similarly, to stents placed into Schlemm’s canal, a microcatheter is first inserted into Schlemm’s canal via the trabecular meshwork and circumnavigated 360° within Schlemm’s canal. The microcatheter breaks inner lumen adhesions and opens stenotic areas of the canal. The microcatheter dilates the canal with high molecular weight ocular viscosurgery device fluid (viscodilation) and separates herniations of the trabecular meshwork into the collector channels , thereby reducing intraocular pressure

Description of Medical Condition

Glaucoma is a chronic progressive optic neuropathy characterised by atrophy of the optic nerve and loss of retinal ganglion cells resulting in progressive vision loss and possible blindness open angle glaucoma is the most common form of the disease caused by high intraocular pressure. The drainage angle formed by the cornea and iris remains open, but the trabecular meshwork is partially blocked. This causes pressure in the eye to gradually increase.

Reason for Application

Amendment to MBS item

Medical Service Type

Therapeutic

Previous Application Number/s

Not Applicable

Associated Documentation

Application Form

Application Form (PDF 1132 KB)
Application Form (Word 116 KB)

Consultation Survey

Consultation Survey (PDF 560 KB)
Consultation Survey (Word 70 KB)

PICO Confirmation

PICO Confirmation (PDF 1647 KB)
PICO Confirmation (Word 771 KB)

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 643 KB)
Public Summary Document (Word 216 KB)

Meetings for this Application

PASC

10 December 2020

ESC

7-8 October 2021

MSAC

25-26 November 2021